ReviewCurrent treatment options in oncology2016

New Targeted Agents in Gynecologic Cancers: Synthetic Lethality, Homologous Recombination Deficiency, and PARP Inhibitors.

Fong W Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.